Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

January 2, 2024

https://www.globenewswire.com/news-release/2024/01/02/2802935/0/en/Journey-Medical-Corporation-Secures-Credit-Facility-with-SWK-Holdings-for-up-to-20-Million.html

SCOTTSDALE, Ariz., Jan. 02, 2024 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq:DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that the Company has entered into a credit facility with an affiliate of SWK Holdings Corporation (“SWK”), a specialized finance company with a focus on the global healthcare sector, providing for borrowings of up to $20 million (“Credit Facility”).

Read more at globenewswire.com

Related news for (DERM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.